Sedana Medical's Sedaconda Study Awarded at DGIIN & ÖGIAIN

In ICU
Tue, 22 Jun 2021

Sedana Medical AB (publ) today announced that the company's pivotal phase III study Sedaconda (SED001) has been named one of the three best posters at the 52nd intensive care conference DGIIN & ÖGIAIN 16–18 June 2021.

"It is very positive that the Sedaconda study is receiving this attention in Germany, which is our largest market. The strong study results form the basis for our ongoing market application and if all goes well, we expect to be able to launch the treatment inhaled sedation in Europe during the second half of this year,” said Jens Lindberg, Acting CEO of Sedana Medical.

DGIIN & ÖGIAIN is the joint annual meeting of the German and Austrian emergency medicine and intensive care societies.

«« Human Connection in the Time of COVID-19

Prone Positioning and Survival in Mechanically Ventilated COVID-19 Patients »»

intensive care, emergency medicine, Sedana Medical, Sedana Medical's Sedaconda Study, DGIIN & ÖGIAIN, intensive care societies

Latest Articles

Decision-Making in the ICU
- ICU Journal Article
- 19/04/2024
Decision-making in the ICU is a multifaceted process that involves clinical assessment, collaboration among multidisciplinary teams, ethical considerations, evidence-based practice, communication, and continuous adaptation to evolving clinical scenarios. Balancing the complex factors requires
READ MORE
Dealing With Uncertainty in ICU Decision-Making: A Practical Guide
- ICU Journal Article
- 19/04/2024
When the stakes are high, and the path ahead is uncertain, the decisions made, especially if a patient continues to worsen, can be sources of self-torment and can haunt us for a long time. Our goal is to suggest ways to steer decision-making for intensivists in the face of uncertainty by prop
READ MORE
The Least Bad Decision: Crisis Standards of Care After the Pandemic
- ICU Journal Article
- 19/04/2024
COVID-19 was an emergency that lasted for years and left few regions of the world untouched. The pandemic shone a spotlight on both the strengths and weaknesses of our disaster planning. What worked, what did not, and how can we better plan for future emergencies? The COVID-19 pandemic fo
READ MORE

intensive care, emergency medicine, Sedana Medical, Sedana Medical's Sedaconda Study, DGIIN & ÖGIAIN, intensive care societies Sedana Medical AB (publ) today announced that the company's pivotal phase III study Sedaconda (SED001) has been named one of the three best posters at the 52nd intensive care conference DGIIN & ÖGIAIN 16–18 June 2021.